New Indian Drug Policy Expected To Be Approved At Next Meeting
This article was originally published in PharmAsia News
Executive Summary
India's new pharmaceutical policy is expected to be approved at its next meeting, although the date for the meeting has not been set. The Union Minister of Chemical and Fertilisers is considering a draft policy that contains some disagreements between the Chemicals Ministry and the pharmaceutical industry in India over price controls and other provisions. Under the policy as drafted so far, the list of essential medicines under price controls would increase from 74 to 354. The industry has objected to the added inclusions, arguing such a move would adversely affect research and development. (Click here for more